These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 14513883)

  • 21. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemoglobin A1c values and CGM.
    Blevins T
    Diabetes Technol Ther; 2012 Oct; 14(10):971; author reply 972. PubMed ID: 23013204
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    Davidson MB
    JAMA; 2017 Jan; 317(4):363-364. PubMed ID: 28118435
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
    Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
    Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of insulin therapy in type 2 diabetes--current standards and recommendations].
    Aulinger BA; Parhofer KG
    MMW Fortschr Med; 2012 May; 154(9):49-52. PubMed ID: 22715632
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.
    Jeitler K; Horvath K; Berghold A; Gratzer TW; Neeser K; Pieber TR; Siebenhofer A
    Diabetologia; 2008 Jun; 51(6):941-51. PubMed ID: 18351320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
    Aronson R; Reznik Y; Conget I; Castañeda JA; Runzis S; Lee SW; Cohen O;
    Diabetes Obes Metab; 2016 May; 18(5):500-7. PubMed ID: 26854123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).
    Hirao K; Arai K; Yamauchi M; Takagi H; Kobayashi M;
    Diabetes Res Clin Pract; 2008 Jan; 79(1):171-6. PubMed ID: 17919762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.
    Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA
    Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.
    Bretzel RG; Eckhard M; Landgraf W; Owens DR; Linn T
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S260-5. PubMed ID: 19875561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.